Related Experiment Video
Updated: May 12, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends,
Xiaodong Wang1, Di Xiong2, Songli Cui1
1Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.
Background:
Immunoconjugates, particularly antibody drug conjugates, are emerging as clinically relevant options for recurrent or metastatic cervical cancer. A quantitative overview of how this field has evolved over the last decade remains limited.
Methods:
Publications from 2015-2024 were retrieved from the Web of Science Core Collection and Scopus, restricted to English articles and reviews, de-duplicated, and screened by two reviewers, yielding 244 records for analysis. Bibliometric indicators were calculated using bibliometrix in R, while VOSviewer and CiteSpace were used for keyword co-occurrence mapping and burst detection, respectively.
Results:
Output increased markedly after 2021, consistent with a shift toward clinical translation. Keyword mapping identified five interlinked themes spanning clinical safety and toxicity management, hematologic malignancy related translational influences, preclinical mechanisms, gynecologic oncology applications, and clinical trial design with emerging therapeutics. Burst analysis indicated a temporal transition from early model based and mechanistic terms to clinically oriented hotspots, including tissue factor and immunotherapy associated concepts.
Conclusions:
The literature depicts rapid maturation of immunoconjugate research in cervical cancer from foundational studies toward clinically actionable targets, safety optimization, and combination strategies, providing a roadmap for prioritizing future translational efforts.
Insights
Antibody drug conjugates are advancing cervical cancer treatment. Research shows a rapid evolution from foundational studies to clinical applications, focusing on safety, mechanisms, and new therapeutic strategies.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Immunoconjugates, especially antibody drug conjugates (ADCs), show promise for recurrent or metastatic cervical cancer.
- A comprehensive quantitative analysis of the field's evolution over the past decade is lacking.
Purpose of the Study:
- To quantitatively analyze the evolution of immunoconjugate research in cervical cancer over the last decade (2015-2024).
- To identify key research themes, trends, and emerging hotspots in the field.
Main Methods:
- Bibliometric analysis of 244 publications from Web of Science and Scopus (2015-2024).
- Utilized bibliometrix in R for indicator calculation.
- VOSviewer and CiteSpace were employed for keyword co-occurrence mapping and burst detection.
Main Results:
- Publication output significantly increased post-2021, indicating a move towards clinical translation.
- Identified five core research themes: safety/toxicity, hematologic malignancy influences, preclinical mechanisms, gynecologic oncology, and clinical trial design.
- Burst analysis revealed a shift from early mechanistic terms to clinical hotspots like tissue factor and immunotherapy.
Conclusions:
- Immunoconjugate research in cervical cancer has matured rapidly, transitioning from basic science to clinically relevant strategies.
- The findings provide a roadmap for future translational research, emphasizing actionable targets, safety, and combination therapies.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Confocal Fluorescence Microscopy
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Immunocytochemistry and Immunohistochemistry
These...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
